Home > Drug Search >
  • company_query: Avexxin
  •   > 
Drug Filter
Category:
chemistry (21) biology (4)
Status:
NDA Filing (3) Phase Ⅲ (2) Phase Ⅱ (13) Phase Ⅰ (7)
Clinical Stage:
Pending (4) Active (18) Discontinued (3)
Indication:
Acute coronary syndrome (ACS) (1) Alzheimer's disease (AD) (2) Atherosclerosis (1) Breast cancer (2) Chronic pain (1) Cognitive disorders (1) Community-acquired pneumonia (CAP) (1) Gastric cancer (1) Wet age-related macular degeneration (1) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Melanoma (1) Multiple myeloma (MM) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Choriocarcinoma (1) Peptic ulcer (1) Hypoalphalipoproteinaemia (1) Lipid metabolism disorders (1) Prostate cancer (1) Psoriasis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Soft tissue sarcoma (1) Solid tumours (3) Type 2 diabetes (2) Acute pain (AP) (1) Pain (1) Spinal cord injury (1) Glioblastoma (2) Traumatic brain injury (1) Mesothelioma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top